SLB · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $35.71B | $36.29B | $33.13B | $28.09B | $22.93B | $23.60B | $32.92B | $32.81B |
| Research & Development | $709.00M | $749.00M | $711.00M | $634.00M | $554.00M | $580.00M | $717.00M | $702.00M |
| Selling, General & Administrative | $340.00M | $385.00M | $364.00M | $376.00M | $339.00M | $365.00M | $474.00M | $444.00M |
| Operating Income | — | — | $6.52B | $5.01B | $3.37B | $2.40B | $3.98B | $4.19B |
| Interest Expense | $558.00M | $512.00M | $503.00M | $490.00M | $539.00M | $563.00M | $609.00M | $575.00M |
| Income Before Taxes | $4.29B | $5.67B | $5.28B | $4.27B | $2.37B | -$11.30B | -$10.42B | $2.62B |
| Provision for Income Taxes | $840.00M | $1.09B | $1.01B | $779.00M | $446.00M | -$812.00M | -$311.00M | $447.00M |
| Net Income | $3.37B | $4.46B | $4.20B | $3.44B | $1.88B | -$10.52B | -$10.14B | $2.14B |
| Basic EPS | $2.38 | $3.14 | $2.95 | $2.43 | $1.34 | -$7.57 | -$7.32 | $1.54 |
| Diluted EPS | $2.35 | $3.11 | $2.91 | $2.39 | $1.32 | -$7.57 | -$7.32 | $1.53 |
| Basic Shares Outstanding | 1.42B | 1.42B | 1.43B | 1.42B | 1.40B | 1.39B | 1.39B | 1.39B |
| Diluted Shares Outstanding | 1.44B | 1.44B | 1.44B | 1.44B | 1.43B | 1.39B | 1.39B | 1.39B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $2.50 | $2.44 | $2.71 | 11 | ↑3 ↓8 |
| Dec 2027 | $3.21 | $2.99 | $3.37 | 11 | ↑3 ↓8 |
| Dec 2028 | $3.77 | $3.65 | $3.86 | 3 | ↑1 ↓0 |
| Dec 2029 | $4.17 | $4.17 | $4.17 | 1 | ↑1 ↓0 |